Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. J Thorac Oncol. 2010 Jul; 5(7):1048-53.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.